Graft-versus-myeloma
Explore this paper's citation graph
- Type
- review
- Published
- 1998-11-01
- Cited by
- 77
- References
- 56
- OpenAlex
- https://openalex.org/W2331210638
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:209176686
Keywords
Medicine, Multiple myeloma, Disease, Transplantation, Surgery
References
- Graft-versus-leukemia reactions in clinical bone marrow transplantation.
- Autologous GVHD following PBSCT, with evidence for a graft-versus-myeloma effect
- Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.
- Graft-versus-myeloma effect: proof of principle.
- Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long-term survivors.
- Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells.
- Outcome of autologous rescue after failed engraftment of allogeneic marrow.
- Successful in vitro graft-versus-tumor effect against an Ia-bearing tumor using cyclosporine-induced syngeneic graft-versus-host disease in the rat.
- Clinical Practice of Stem-Cell Transplantation
- Graft-versus-leukemia reactions after bone marrow transplantation.
- Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid.
- Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation.
- Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantation.
- Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
- [Allogeneic bone marrow transplantation in multiple myeloma].
- Multiple gastric involvement by myeloid antigen CD13‐positive non‐secretory plasma cell leukaemia
- Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation
- Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft?
- Graft-versus-myeloma effect in two cases.
- T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapse
Cited by
- Evolving indications for hematopoietic stem cell transplantation in multiple myeloma and other plasma cell disorders.
- Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent
- Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma
- Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation.
- Reduced intensity allogeneic stem cell transplantation in multiple myeloma.
- Advances in the autologous and allogeneic transplantation strategies for multiple myeloma.
- Different aspects of thalidomide treatment and stem cell transplantation in multiple myeloma patients
- Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation?
- Multiply recurrent extramedullary plasmacytomas without marrow relapse in the context of extensive chronic GVHD in a patient with myeloma.
- CD34-selected allogeneic hematopoietic stem cell transplantation for patients with relapsed, high-risk multiple myeloma
- HEPATITIS G VIRUS IN PATIENTS WITH HODGKIN'S LYMPHOMA
- Allogeneic bone marrow transplantation with reduced conditioning (RC‐BMT)
- The graft-versus-lymphoma effect: clinical review and future opportunities
- Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation
- Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells
- Autografting followed by a reduced‐intensity conditioning unrelated donor cord blood transplantation for a patient with refractory multiple myeloma: successful engraftment with minimal toxicity
- Multiple Myeloma: Diagnosis and Treatment.
- Allogeneic haematopoietic cell transplantation for multiple myeloma: reducing transplant-related mortality while harnessing the graft-versus-myeloma effect.
- Detection of minimal residual disease by real-time PCR can be used as a surrogate marker to evaluate the graft-versus-myeloma effect after allogeneic stem cell transplantation
- Peripheral Blood Stem Cells for Allogeneic Transplantation: A Review
Related papers
- Expression of MicroRNA-221 in Korean Patients with Multiple Myeloma
- [Autologous transplantation of peripheral hematopoietic cells in a patient with multiple myeloma and renal insufficiency].
- Multiple myeloma with double clones of IgG-κ and IgG-λ: A case report and review of the literatures
- Presenting signs and symptoms in multiple myeloma: high percentages of stage III among patients without apparent myeloma-associated symptoms
- Mechanism of immunomodulatory drugs in multiple myeloma.
- [The patient complains of spinal pain or fatigue and weakness. How do I recognize whether their cause is spondylarthrosis, the patients age or multiple myeloma?].
- [Autopsy-statistical analysis of multiple myeloma (author's transl)].
- A new hope for patients suffering from multiple myeloma
- Immunopathology of cutaneous graft-versus-host disease.